Not medical advice. Talk to your provider before using any peptide.
Full disclaimerPeptide Schedule Research TeamReviewed Apr 20266 Citations
Pinealon3 residuesEDREach bubble = one amino acid. Size = residue mass. Color = chemical class.Pinealon (EDR) is a three-amino-acid bioregulator targeting the pineal gland's melatonin and serotonin pathways. Preclinical data from the Khavinson group shows neuroprotective gene modulation. No human trials exist, but community users report circadian rhythm correction over short 10 to 20 day cycles.
100mcg · Daily
Summary: Add 2mL BAC water to your 20mg vial. Draw to 1.0 units on a U-100 syringe for a 100mcg dose. This vial will last 200 doses.
View side effects and safety warnings →
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 100mcg | Daily |
| Moderate | 200mcg | Daily |
| Aggressive | 200mcg | Daily |
Start with the math. A 20 mg vial reconstituted with 2 mL bacteriostatic water gives you 10,000 mcg per mL, or 100 mcg per unit on a U100 insulin syringe. So your beginner dose of 100 mcg is 1 unit. Moderate (200 mcg) is 2 units. At 200 mcg per day, one vial lasts 100 days, well beyond a single 10 to 30 day course. Dose in the evening, 1 to 2 hours before sleep. This aligns with the natural melatonin rise and matches the Khavinson protocol. The most common mistake is confusing mcg (injectable) with mg (oral). A 200 mcg subcutaneous dose is not the same as 200 mg oral. Swapping those units creates a greater than 1,000-fold error. Subcutaneous doses are in micrograms. Oral capsule doses are in milligrams. Double-check your units every time. Skip caffeine within 6 hours of your evening dose. Store reconstituted vials at 2 to 8 degrees Celsius and use within 3 weeks.
Dosing based on Khavinson Institute protocol — 8 published references.View all sources →
Cross-check your Pinealon reconstitution math with AI
Pricing updated 2026-04-09
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Pinealon (EDR) is a three-amino-acid bioregulator targeting the pineal gland's melatonin and serotonin pathways. Preclinical data from the Khavinson group shows neuroprotective gene modulation. No human trials exist, but community users report circadian rhythm correction over short 10 to 20 day cycles.
